Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

OBJECTIVE To assess recent trends in nonalcoholic fatty liver disease (NAFLD) prevalence among US adolescents. STUDY DESIGN Cross-sectional data from 12 714 12-19 year olds (exclusions: chronic hepatitis, hepatotoxic medications) in the National Health and Examination Survey between 1988-1994 and 2007-2010 were used to estimate trends in suspected NAFLD, defined as overweight (body mass index ≥85th percentile) plus elevated alanine aminotransferase levels (boys >25.8 U/L; girls >22.1 U/L). Linear trends in prevalence and the independent effect of demographic indicators and adiposity on NAFLD risk were tested using regression models. Complex sampling methods and P values of <.05 were used to assess statistical significance. RESULTS Suspected NAFLD prevalence (SE) rose from 3.9% (0.5) in 1988-1994 to 10.7% (0.9) in 2007-2010 (P < .0001), with increases among all race/ethnic subgroups, males and females, and those obese (P trend ≤.0006 for all). Among those obese, the multivariate adjusted odds of suspected NAFLD were higher with increased age, body mass index, Mexican American race, and male sex; the adjusted odds in 2007-2010 were 2.0 times those in 1988-1994. In 2007-2010, 48.1% (3.7) of all obese males and 56.0% (3.5) of obese Mexican American males had suspected NAFLD. CONCLUSION Prevalence of suspected NAFLD has more than doubled over the past 20 years and currently affects nearly 11% of adolescents and one-half of obese males. The rapid increase among those obese, independent of body mass index, suggests that other modifiable risk factors have influenced this trend.

[1]  C. Smith,et al.  Risk for Nonalcoholic Fatty Liver Disease in Hispanic Youth With BMI ≥95th Percentile , 2007, Journal of pediatric gastroenterology and nutrition.

[2]  E. Gunter,et al.  Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 , 1996 .

[3]  J. Kimmons,et al.  Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. , 2008, Medscape journal of medicine.

[4]  P. Rosenthal,et al.  Correlation of Vitamin E, Uric Acid, and Diet Composition With Histologic Features of Pediatric NAFLD , 2012, Journal of pediatric gastroenterology and nutrition.

[5]  J. Després,et al.  Mapping body fat distribution: A key step towards the identification of the vulnerable patient? , 2012, Annals of medicine.

[6]  R. Deutsch,et al.  Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents , 2005, Pediatrics.

[7]  N. Stettler,et al.  Ethnic and Sex Differences in the Association Between Metabolic Syndrome and Suspected Nonalcoholic Fatty Liver Disease in a Nationally Representative Sample of US Adolescents , 2009, Journal of pediatric gastroenterology and nutrition.

[8]  K. Flegal,et al.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. , 2012, JAMA.

[9]  C. McClain,et al.  Nutrition and nonalcoholic fatty liver disease in children , 2008, Current gastroenterology reports.

[10]  W. Dietz,et al.  Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. , 2000, The Journal of pediatrics.

[11]  S. Grundy,et al.  Rationale of the diet-heart statement of the American Heart Association. Report of the AHA nutrition committee. , 1982, Arteriosclerosis.

[12]  S. Barlow,et al.  Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. , 2007, Pediatrics.

[13]  A F Roche,et al.  CDC growth charts: United States. , 2000, Advance data.

[14]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[15]  G. Siest,et al.  Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. , 1975, Clinical chemistry.

[16]  D. Burns,et al.  Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[17]  Effect of Pyrldoxal 5-Phosphate on the Stability of Alanlne Aminotransferase , 2022 .

[18]  G. Takada,et al.  Serum alanine aminotransferase activity in obese children , 1997, Acta paediatrica.

[19]  A. Zanella,et al.  Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.

[20]  M. Feinleib.  National Center for Health Statistics (NCHS) , 2005 .

[21]  R. Xu,et al.  Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study , 2008, The American Journal of Gastroenterology.

[22]  G. Norman,et al.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. , 2010, Gastroenterology.

[23]  D. Allison,et al.  Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. , 2004, The Journal of pediatrics.